PubMed

The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes.

Meerwaldt R, Links T, Zeebregts C, Tio R, Hillebrands JL, Smit A.

Cardiovasc Diabetol. 2008 Oct 7;7:29. Review.PMID: 18840258 [PubMed - indexed for MEDLINE]Related articlesFree article

Advanced glycation end products (AGEs) and cardiovascular disease (CVD) in diabetes.

Yamagishi S, Matsui T, Ueda S, Nakamura K, Imaizumi T.

Cardiovasc Hematol Agents Med Chem. 2007 Jul;5(3):236-40. Review.PMID: 17630950 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular disease in diabetes.

Yamagishi S, Nakamura K, Matsui T, Takenaka K, Jinnouchi Y, Imaizumi T.

Mini Rev Med Chem. 2006 Mar;6(3):313-8. Review.PMID: 16515470 [PubMed - indexed for MEDLINE]Related articles

Advanced glycation end products and diabetic complications.

Stitt AW, Jenkins AJ, Cooper ME.

Expert Opin Investig Drugs. 2002 Sep;11(9):1205-23. Review.PMID: 12225243 [PubMed - indexed for MEDLINE]Related articles

Clinical relevance of advanced glycation endproducts for vascular surgery.

Meerwaldt R, van der Vaart MG, van Dam GM, Tio RA, Hillebrands JL, Smit AJ, Zeebregts CJ.

Eur J Vasc Endovasc Surg. 2008 Aug;36(2):125-31. Epub 2008 Mar 19. Review.PMID: 18356091 [PubMed - indexed for MEDLINE]Related articles

The role of AGEs in cardiovascular disease.

Jandeleit-Dahm K, Cooper ME.

Curr Pharm Des. 2008;14(10):979-86. Review.PMID: 18473849 [PubMed - indexed for MEDLINE]Related articles

Accumulation of advanced glycation end products and chronic complications in ESRD treated by dialysis.

Meerwaldt R, Zeebregts CJ, Navis G, Hillebrands JL, Lefrandt JD, Smit AJ.

Am J Kidney Dis. 2009 Jan;53(1):138-50. Epub 2008 Nov 25. Review.PMID: 19036487 [PubMed - indexed for MEDLINE]Related articles

Approaches to prevention of cardiovascular complications and events in diabetes mellitus.

Coccheri S.

Drugs. 2007;67(7):997-1026. Review.PMID: 17488145 [PubMed - indexed for MEDLINE]Related articles

The clinical relevance of advanced glycation endproducts (AGE) and recent developments in pharmaceutics to reduce AGE accumulation.

Smit AJ, Lutgers HL.

Curr Med Chem. 2004 Oct;11(20):2767-84. Review.PMID: 15544475 [PubMed - indexed for MEDLINE]Related articles

Blockade of the advanced glycation end products (AGEs) and their receptor (RAGE) system is a possible mechanism for sustained beneficial effects of multifactorial intervention on mortality in type 2 diabetes.

Yamagishi S, Matsui T, Nakamura K.

Med Hypotheses. 2008 Nov;71(5):749-51. Epub 2008 Aug 16.PMID: 18710793 [PubMed - indexed for MEDLINE]Related articles

[Diabetes mellitus, oxidative stress and advanced glycation endproducts]

Bonnefont-Rousselot D, Beaudeux JL, Thérond P, Peynet J, Legrand A, Delattre J.

Ann Pharm Fr. 2004 May;62(3):147-57. Review. French. PMID: 15243348 [PubMed - indexed for MEDLINE]Related articles

Inhibitors of advanced glycation end products (AGEs): potential utility for the treatment of cardiovascular disease.

Yamagishi S, Nakamura K, Matsui T, Ueda S, Noda Y, Imaizumi T.

Cardiovasc Ther. 2008 Spring;26(1):50-8. Review.PMID: 18466420 [PubMed - indexed for MEDLINE]Related articles

Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients.

Yamagishi S, Nakamura K, Inoue H.

Med Hypotheses. 2005;65(6):1013-5.PMID: 16146671 [PubMed - indexed for MEDLINE]Related articles

Clinical review 2: The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications?

Ceriello A, Ihnat MA, Thorpe JE.

J Clin Endocrinol Metab. 2009 Feb;94(2):410-5. Epub 2008 Dec 9. Review.PMID: 19066300 [PubMed - indexed for MEDLINE]Related articlesFree article

Receptor for advanced glycation end-products (RAGE) and soluble RAGE (sRAGE): cardiovascular implications.

Lindsey JB, Cipollone F, Abdullah SM, McGuire DK.

Diab Vasc Dis Res. 2009 Jan;6(1):7-14. Review.PMID: 19156622 [PubMed - indexed for MEDLINE]Related articles

[Therapeutic intervention in diseases with advanced glycation end products in their pathogenesis]

Zuwała-Jagiełło J.

Pol Merkur Lekarski. 2009 Aug;27(158):152-6. Review. Polish. PMID: 19856885 [PubMed - indexed for MEDLINE]Related articles

Characterisation of advanced glycation endproducts in saliva from patients with diabetes mellitus.

Yoon MS, Jankowski V, Montag S, Zidek W, Henning L, Schlüter H, Tepel M, Jankowski J.

Biochem Biophys Res Commun. 2004 Oct 15;323(2):377-81.PMID: 15369762 [PubMed - indexed for MEDLINE]Related articles

[Antioxidant and anti-AGE therapeutics: evaluation and perspectives]

Bonnefont-Rousselot D.

J Soc Biol. 2001;195(4):391-8. Review. French. PMID: 11938556 [PubMed - indexed for MEDLINE]Related articles

Receptor for advanced glycation end products and the cardiovascular complications of diabetes and beyond: lessons from AGEing.

Yan SF, Yan SD, Herold K, Ramsamy R, Schmidt AM.

Endocrinol Metab Clin North Am. 2006 Sep;35(3):511-24, viii. Review.PMID: 16959583 [PubMed - indexed for MEDLINE]Related articles

Towards newer molecular targets for chronic diabetic complications.

Khan ZA, Farhangkhoee H, Chakrabarti S.

Curr Vasc Pharmacol. 2006 Jan;4(1):45-57. Review.PMID: 16472176 [PubMed - indexed for MEDLINE]Related articles